Menu
Search
|

Menu

Close
X

Mazor Robotics Ltd MZOR.OQ (NASDAQ Stock Exchange Global Market)

60.54 USD
-1.25 (-2.02%)
As of Feb 16
chart
Previous Close 61.79
Open 61.99
Volume 118,373
3m Avg Volume 165,181
Today’s High 62.63
Today’s Low 60.48
52 Week High 69.13
52 Week Low 21.66
Shares Outstanding (mil) 26.15
Market Capitalization (mil) 1,611.25
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.80 Mean rating from 5 analysts

KEY STATS

Revenue (mm, USD)
FY17
64
FY16
36
FY15
26
EPS (USD)
FY17
-0.253
FY16
-0.417
FY15
-0.364
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
34.43
Price to Sales (TTM)
vs sector
24.81
8.57
Price to Book (MRQ)
vs sector
13.62
5.14
Price to Cash Flow (TTM)
vs sector
--
25.75
Total Debt to Equity (MRQ)
vs sector
--
15.12
LT Debt to Equity (MRQ)
vs sector
--
11.85
Return on Investment (TTM)
vs sector
-13.85
13.54
Return on Equity (TTM)
vs sector
-13.90
14.80

EXECUTIVE LEADERSHIP

Jonathan Adereth
Chairman of the Board, Since 2007
Salary: --
Bonus: --
Ori Hadomi
Chief Executive Officer, Director, Since 2003
Salary: 956,600.00₪
Bonus: --
Sharon Levita
Chief Financial Officer, Vice President - Business Operations, Secretary, Since 2017
Salary: 572,114.00₪
Bonus: --
Christopher Prentice
Chief Commercial Officer, Chief Executive Officer of Mazor Inc, Since 2017
Salary: --
Bonus: --
Eliyahu Zehavi
Chief Operating Officer, Executive Vice President of Advanced Technologies, Since 2017
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Advanced Medical Equipment & Technology
Address:

5 Shacham St., North Industrial
CAESAREA     3088900

Phone: +9724.6187100

Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications. Its Renaissance System and its predecessor are used in a number of spine surgeries, including fusion, correction of spinal deformities, biopsy collection, tumor excision and cement augmentations. Furthermore the Company developed the Renaissance Brain Module, an application of its Renaissance System that provides control over the insertion of surgical instruments during brain surgery.

SPONSORED STORIES